Table: Taiko Pharmaceutical -2020 group results

Taiko Pharmaceutical

12/02/2021 06:01

Feb 12 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2020    Mar 31, 2020   Dec 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             17.58           14.97          22.00                 
                                 (+43.6 pct)                             
  Operating          5.65            3.82           4.50                 
                                 (+88.4 pct)                             
  Recurring          5.45            3.63           4.40                 
                                 (+92.7 pct)                             
  Net
  Net                3.85            2.45           3.10                 
                                 (+73.3 pct)                             
  EPS             89.18 yen       57.57 yen      71.57 yen               
  EPS Diluted     88.82 yen       57.34 yen                              
  Ann Div         25.00 yen       50.00 yen      20.00 yen               
  -Q2 Div         7.00 yen        10.00 yen      7.00 yen                
  -Q4 Div         18.00 yen       40.00 yen      13.00 yen               
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T